Literature DB >> 3780837

A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.

L Dodion, Y Ambroes, N Lameire.   

Abstract

The diuretic effects of torasemide and furosemide at three different steady-state plasma and urinary drug levels were compared in a randomized cross-over study in 6 healthy volunteers. Each trial with either torasemide or furosemide consisted of four consecutive periods of 90 min, the first being a control period, and during the three other periods, increasing doses of drug were administered. Each 90-min period was itself divided into three 30 min blood sampling and urinary collection periods. The urinary losses of water and electrolytes were compensated within each 30-min period by intravenous infusion of saline (NaCl) and 5% glucose solutions, to which KCl was added. A constant dose of calcium gluconate was given to compensate, at least in part, any calcium loss. Data from each 30 min control and the 3 drug dose periods, corresponding to full steady-state conditions, were used for clearance determinations and measurement of plasma and urinary drug concentrations. Urine volume, osmolar clearance, absolute and fractional urinary excretion of sodium, potassium, chloride, calcium and magnesium and creatinine clearance increased similarly after torasemide and furosemide according to the logarithm of the dose of the drug. Free water clearance stabilized at a constant level with torasemide and increased continuously after each dose of furosemide. During each of the three drug administration periods, the plasma levels of torasemide were not significantly different from those of furosemide, whereas the urinary concentrations and absolute excretion rates of torasemide were more than 5-times lower than those of furosemide.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3780837     DOI: 10.1007/bf00541463

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  [RENAL HEMODYNAMICS, WATER AND ELECTROLYTE ELIMINATION AFTER 4-CHLORO-N-(2-FURYLETHYL)-5-SULFAMOYLANTHRANILIC ACID].

Authors:  A HEIDLAND; K KLUETSCH; F SUZUKI
Journal:  Arzneimittelforschung       Date:  1964-06

Review 2.  [Diuretics in reduced kidney function].

Authors:  C Vorburger
Journal:  Internist (Berl)       Date:  1971-08       Impact factor: 0.743

3.  Differences in the acute effects of furosemide and ethacrynic acid in man.

Authors:  J H Stein; C B Wilson; W M Kirkendall
Journal:  J Lab Clin Med       Date:  1968-04

4.  Quantitative analysis of furosemide in micro plasma volumes by high-performance liquid column chromatography.

Authors:  R L Nation; G W Peng; W L Chiou
Journal:  J Chromatogr       Date:  1979-01-01

5.  Cellular mechanism of the action of loop diuretics on the thick ascending limb of Henle's loop.

Authors:  R Greger; E Schlatter
Journal:  Klin Wochenschr       Date:  1983-10-17

6.  Glomerular filtration during furosemide diuresis in the dog.

Authors:  T J Burke; K L Duchin
Journal:  Kidney Int       Date:  1979-12       Impact factor: 10.612

7.  Bumetanide and frusemide: a comparison of dose-response curves in healthy men.

Authors:  L E Ramsay; G T McInnes; J Hettiarachchi; J Shelton; P Scott
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

8.  Relationship of urinary furosemide excretion rate to natriuretic effect in experimental azotemia.

Authors:  H J Rose; A W Pruitt; P G Dayton; J L McNay
Journal:  J Pharmacol Exp Ther       Date:  1976-12       Impact factor: 4.030

9.  Azosemide, a "loop" diuretic, and furosemide.

Authors:  D C Brater; S A Anderson; S Strowig
Journal:  Clin Pharmacol Ther       Date:  1979-04       Impact factor: 6.875

10.  Pharmacological properties of the new potent diuretic torasemide in rats and dogs.

Authors:  A Ghys; J Denef; J M de Suray; M Gerin; A Georges; J Delarge; J Willems
Journal:  Arzneimittelforschung       Date:  1985
View more
  4 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of torasemide.

Authors:  H Knauf; E Mutschler
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

Review 2.  Torasemide. A review of its pharmacological properties and therapeutic potential.

Authors:  H A Friedel; M M Buckley
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

3.  Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.

Authors:  A J Scheen; J C Vancrombreucq; J Delarge; A S Luyckx
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Effects of tolvaptan on urine output in hospitalized heart failure patients with hypoalbuminemia or proteinuria.

Authors:  Koji Takagi; Naoki Sato; Shiro Ishihara; Michiko Sone; Hideo Tokuyama; Kenji Nakama; Toshiya Omote; Arifumi Kikuchi; Masahiro Ishikawa; Kenichi Amitani; Naoto Takahashi; Yuji Maruyama; Hajime Imura; Wataru Shimizu
Journal:  Heart Vessels       Date:  2017-10-23       Impact factor: 2.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.